GLP-1 agonists: Addressing side effects of weight loss drugs
Meeting Announcement
Updates every hour. Last Updated: 2-Jan-2026 12:11 ET (2-Jan-2026 17:11 GMT/UTC)
New research is uncovering how medications targeting the glucagon-like peptide-1 (GLP-1) system affect brain circuits involved in nausea, thirst, and pleasurable behaviors. These findings will be presented at Neuroscience 2025, the annual meeting of the Society for Neuroscience and the world’s largest source of emerging news about brain science and health.
Researchers are shedding light on neural mechanisms underlying the progression of Alzheimer's disease. These findings will be presented at Neuroscience 2025, the annual meeting of the Society for Neuroscience and the world’s largest source of emerging news about brain science and health.
Our body’s “blood factory” consists of specialized tissue made up of bone cells, blood vessels, nerves and other cell types. Now, researchers have succeeded for the first time in recreating this cellular complexity in the laboratory using only human cells. The novel system could reduce the need for animal experiments for many applications.